Cite
HARVARD Citation
McIlroy, G. et al. (2020). Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 61 (1), pp. 202-205. [Online].